|
rdf:type |
|
|
lifeskim:mentions |
umls-concept:C0015915,
umls-concept:C0018120,
umls-concept:C0019927,
umls-concept:C0023610,
umls-concept:C0073629,
umls-concept:C0178602,
umls-concept:C0221971,
umls-concept:C0439064,
umls-concept:C0593515,
umls-concept:C0733758,
umls-concept:C0876720,
umls-concept:C0949385,
umls-concept:C1136455,
umls-concept:C1527148,
umls-concept:C1571705
|
|
pubmed:issue |
4
|
|
pubmed:dateCreated |
2001-4-5
|
|
pubmed:abstractText |
To investigate relations between dose of GnRH antagonist and follicular phase characteristics.
|
|
pubmed:commentsCorrections |
|
|
pubmed:language |
eng
|
|
pubmed:journal |
|
|
pubmed:citationSubset |
IM
|
|
pubmed:chemical |
|
|
pubmed:status |
MEDLINE
|
|
pubmed:month |
Apr
|
|
pubmed:issn |
0015-0282
|
|
pubmed:author |
|
|
pubmed:issnType |
Print
|
|
pubmed:volume |
75
|
|
pubmed:owner |
NLM
|
|
pubmed:authorsComplete |
Y
|
|
pubmed:pagination |
688-93
|
|
pubmed:dateRevised |
2006-11-15
|
|
pubmed:meshHeading |
pubmed-meshheading:11287020-Adolescent,
pubmed-meshheading:11287020-Adult,
pubmed-meshheading:11287020-Embryo Transfer,
pubmed-meshheading:11287020-Estradiol,
pubmed-meshheading:11287020-Female,
pubmed-meshheading:11287020-Fertilization in Vitro,
pubmed-meshheading:11287020-Follicle Stimulating Hormone,
pubmed-meshheading:11287020-Follicle Stimulating Hormone, Human,
pubmed-meshheading:11287020-Gonadotropin-Releasing Hormone,
pubmed-meshheading:11287020-Hormone Antagonists,
pubmed-meshheading:11287020-Humans,
pubmed-meshheading:11287020-Luteinizing Hormone,
pubmed-meshheading:11287020-Menstrual Cycle,
pubmed-meshheading:11287020-Ovarian Follicle,
pubmed-meshheading:11287020-Ovulation Induction,
pubmed-meshheading:11287020-Pregnancy,
pubmed-meshheading:11287020-Progesterone,
pubmed-meshheading:11287020-Recombinant Proteins,
pubmed-meshheading:11287020-Regression Analysis,
pubmed-meshheading:11287020-Treatment Outcome
|
|
pubmed:year |
2001
|
|
pubmed:articleTitle |
Dynamics of the development of multiple follicles during ovarian stimulation for in vitro fertilization using recombinant follicle-stimulating hormone (Puregon) and various doses of the gonadotropin-releasing hormone antagonist ganirelix (Orgalutran/Antagon).
|
|
pubmed:affiliation |
Division of Reproductive Medicine, Department of Obstetrics and Gynecology, Erasmus University Medical Center Rotterdam, Rotterdam, The Netherlands.
|
|
pubmed:publicationType |
Journal Article,
Clinical Trial,
Comparative Study,
Randomized Controlled Trial,
Multicenter Study
|
